Prostatype Genomics AB
PROGEN SE0014684569
ICB 2010 : Health Care / Health CareAnnual Performance 1
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 5530% | 2237% | 1937% | 12288% | -18% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Michael Häggman DIR |
0.02 SEK |
41,058,205 Bought |
821,164 SEK |
26/09/2024 | 23/09/2024 |
| Michael Häggman DIR |
0.01 SEK |
32,500,000 Bought |
325,000 SEK |
30/09/2024 | 23/09/2024 |
| Anders Lundberg CB |
0.02 SEK |
1,187,913 Sold |
27,916 SEK |
09/09/2024 | 06/09/2024 |
| Anders Lundberg CB |
0.02 SEK |
464,653 Sold |
11,152 SEK |
09/09/2024 | 05/09/2024 |
| Anders Lundberg CB |
0.02 SEK |
97,283 Sold |
2,043 SEK |
09/09/2024 | 04/09/2024 |
| Anders Lundberg CB |
2.12 SEK |
20,000 Bought |
42,400 SEK |
11/11/2022 | 11/11/2022 |
| Anders Lundberg CB |
2.01 SEK |
20,000 Bought |
40,200 SEK |
11/11/2022 | 10/11/2022 |
| Karl Fredrik Persson CEO |
2.25 SEK |
35,000 Bought |
78,750 SEK |
10/11/2022 | 10/11/2022 |
| Karl Fredrik Persson CEO |
9.01 SEK |
8,000 Bought |
72,080 SEK |
06/12/2021 | 06/12/2021 |
| Anders Lundberg CB |
9.30 SEK |
5,000 Bought |
46,475 SEK |
30/11/2021 | 29/11/2021 |